Phosphatidylserine in Gummies: Formulation and Sourcing Review for US and EU Brands

Phosphatidylserine (PS) is a phospholipid powder, and a gummy is a high-moisture, heat-processed sugar matrix, so "PS in gummies" is an application-fit question, not a simple label change. The direct answer for a buyer is to treat a gummy launch as its own formulation and documentation review: confirm that the finished product is a food supplement or functional food in your destination market and that the dose form is accepted, choose the PS source and grade against sensory, process, and label needs, set specifications for both the powder and the gummy matrix (water activity, assay recovery, stability), request samples and application support before bulk commitment, and keep every claim inside US structure/function rules and the EU nutrition and health claims framework. A supplier that can document specification, COA, and batch evidence for the powder still cannot guarantee the finished gummy; that is the formulator's file.

This guide is written for procurement, formulation, and quality teams behind US and EU supplement and functional food projects. It is operational sourcing guidance, not legal, regulatory, or medical advice.

Why Gummies Are a Different Buyer Question Than Capsules or Tablets

The format changes what the ingredient must tolerate

Most PS sourcing questions assume the ingredient ends up in a capsule, tablet, or powder: a low-moisture, controlled process where the powder's identity, assay, and flow are the main concerns. A gummy changes the boundary conditions. The PS is mixed into a warm, high-sugar, water-containing mass, held at elevated temperature during depositing, then cooled into a gel that retains significant moisture for its whole shelf life. That sequence tests four things at once: heat exposure during syrup preparation and depositing, which can affect assay recovery; moisture equilibration between the powder and the gummy matrix, which changes water activity over time; sensory fit, because a phospholipid powder can bring its own taste, odor, and mouthfeel; and uniformity, because the ingredient must be dispersed consistently so each serving delivers a consistent amount. None of these are answered by the COA alone; they are answered by a formulation plan, samples, and trials with the actual matrix.

Gummies are an established supplement format in the US; dose-form rules vary in the EU

In the United States, the FDA describes dietary supplements as products ingested in many forms, "including tablets, capsules, soft gels, gel caps, powders, bars, gummies, and liquids." Gummy is therefore a recognized supplement format at the federal level. In the EU, food supplements are defined under Directive 2002/46/EC as concentrated sources of nutrients or other substances with a nutritional or physiological effect marketed "in dose form," with examples such as capsules, pastilles, tablets, pills, and sachets of powder. Gummies are not named in the definition, so their classification depends on how the finished product is presented and how the relevant member state interprets "other similar forms." Confirm this early, before formulation and artwork, because it changes which rules apply.

What a PS Buyer Should Verify Before a Gummy Project

Define the finished product first

Start with the destination market, the product category (food supplement versus functional food), the serving concept, the claim intent, and the target PS amount per serving. These decisions drive source, grade, specification, testing, and documents. A PS gummy planned for the US and one planned for an EU member state will not follow identical rules and should not share a specification without review.

Choose the source: soy or sunflower

Nutranexa supplies PS from two documented routes: soy phosphatidylserine و sunflower phosphatidylserine. The source choice affects allergen positioning, label statements, and raw-material preferences, not necessarily the gummy process itself. If soy allergen labeling matters or the brand wants a non-soy position, sunflower PS is the relevant route; otherwise soy PS is a conventional option. Compare the routes against the finished label before quotation. The soy versus sunflower PS supplier review covers this decision in detail.

Choose the grade with samples in mind

PS is supplied at different assay levels. Nutranexa lists PS 20%, PS 50%, and PS 70% grade options, and the right choice for a gummy depends on the target mg-per-serving, the powder loading the gummy mass can carry without sensory or texture problems, and the cost position. A lower-assay grade requires a larger powder addition for the same PS amount; a higher-assay grade reduces powder load but may concentrate flavor or carrier effects. There is no universal "gummy grade": the decision is made with the target formula and a sample in hand. Request current specifications for each candidate grade and confirm which source routes are available for the quoted grade.

Set the powder specification before the gummy specification

The PS powder specification review lists the parameters that matter for any format. For a gummy project, three powder parameters deserve special attention:

The moisture and water activity review and the particle size distribution review explain how to read these rows and what to request when a parameter is not shown on the COA.

Technical Checks That Matter in a Gummy Matrix

Water activity drives shelf life and microbial risk

Gummies are intermediate-moisture products. FDA's water activity guidance explains that aw predicts which microorganisms can grow in a product and how stable it is over time; water activity, not water content alone, is the practical control point. The ingredient and the finished gummy each contribute to the final aw, so the specification file should cover the gummy's target aw and test method, not only the powder's moisture.

Assay recovery and stability need their own study

A PS gummy can test below the theoretical addition if the assay method does not extract PS from the sugar-gel matrix, or if heat or interaction with other ingredients reduces recovery. That is why the stability study review recommends confirming assay at release and at shelf-life time points with the actual finished matrix. Ask the contract manufacturer to confirm that PS assay, moisture, water activity, and sensory are checked at each time point.

Sensory fit is part of the specification

PS powders are typically fine, light-colored powders with a phospholipid character. In a gummy, the brand must decide whether the PS flavor and mouthfeel are masked by the flavor system or acceptable at the target loading. This is a sample question: evaluate the powder alone, in a bench gummy, and in the production-scale trial, and record taste, odor, color, and texture so the bulk specification matches the sensory expectations.

Process fit decides how the powder enters the mass

The gummy manufacturer will either disperse the powder into the syrup or oil-based phase or dry-blend it with other actives before hydration. The flowability and blend uniformity pilot review explains how powder behavior affects dosing and blending. For gummies, the practical questions are the addition point, mixing time and temperature, and how the batch is sampled for uniformity. Confirm these with the contract manufacturer and ask the ingredient supplier for application support for the quoted grade.

Need current PS specifications, COA samples, and source evidence to evaluate a gummy project? Request the specification and document package with your target market, application, source preference, and target assay.

US and EU Positioning for PS Gummies

United States: supplement labeling and structure/function claims

In the US, a PS gummy sold as a dietary supplement carries a Supplement Facts panel, which the Supplement Facts label review explains in detail; claims are the second discipline. Under DSHEA, structure/function claims describe the role of a nutrient or ingredient in affecting normal structure or function; FDA does not pre-approve them, but the manufacturer must substantiate the claim, notify FDA within 30 days of first marketing, and include the disclaimer that FDA has not evaluated it and the product is not intended to diagnose, treat, cure, or prevent disease. Disease claims are not allowed. The distinction lives in 21 CFR 101.93 and in FDA's structure/function claims guidance.

European Union: food supplement rules, labeling, and the health claims framework

In the EU, a PS gummy marketed as a food supplement must meet the national rules implementing Directive 2002/46/EC, including dose-form classification, labelling requirements under Regulation (EU) 1169/2011, and the general prohibition on claiming that a food prevents, treats, or cures disease. Health claims are governed by Regulation (EC) 1924/2006 and may be used only if authorized and listed. For PS specifically, the EFSA Panel assessed claims related to memory, cognitive function, and stress under Article 13(1) and concluded that a cause and effect relationship could not be established; no Article 13.1 health claims for phosphatidylserine were authorized on that basis. EU brand teams should therefore plan PS gummy labels without cognitive or memory health claims, and confirm the national position with a regulatory adviser.

Supplier Questions to Ask Before Ordering PS for a Gummy Launch

Add these to the quotation and qualification workflow:

1. Which source routes (soy or sunflower) are available for the quoted PS grade, and which documents exist for each?
2. What are the current specification and COA for the candidate grade, including assay, moisture, peroxide value, and test basis?
3. What particle-size data is available, and what mixing or dispersion approach is recommended for a high-sugar, high-moisture matrix?
4. Can samples be supplied for bench gummy trials, and what quantity and lead time apply?
5. Is finished-matrix stability data available, or does the brand need to run its own study with the contract manufacturer?
6. What MOQ, packaging, and shipment details apply? Nutranexa's PS standard is a 25 kg MOQ with 25 kg net per drum.
7. Which certificates and statements are available (for example Halal, Kosher, food production license, and FDA food facility registration documents) and are they current and in scope for the quoted product?

Record the answers in the supplier onboarding file and review them with the same discipline as the COA and specification review. Keep the powder documents separate from the finished-gummy file: the COA proves what the powder is, while release testing, stability data, and label documents prove what the finished product is.

From Sample to Bulk: The Gummy Project Workflow

1. Define the market, product category, serving size, target PS amount, source, and claim intent.
2. Request current specifications and COA samples for the candidate grades, and review them against the documents for PS ingredients checklist.
3. Request powder samples and run bench gummy trials covering assay recovery, water activity, sensory, and process fit, then compare results with the sample evaluation checklist before approving bulk.
4. Confirm MOQ, packaging, lead time, and destination-market documents with sales before the order; Nutranexa's PS MOQ is 25 kg, packed at 25 kg net per drum.
5. Plan the finished-product stability study and label compliance work in parallel with procurement, not after delivery.
6. Keep lot-level evidence: the lot traceability checklist links the COA, drum labels, and shipment records to the batch used in formulation.

Nutranexa, founded in 2013 and operating a 110,000+ m2 production campus with R&D cooperation with East China University of Science and Technology, supplies PS as a lead product with public specification and COA evidence. Nutranexa does not claim a finished gummy formula: suitability for a specific matrix is confirmed through samples, specification review, and the brand's own stability and sensory work. Contact the sales team to request current specifications, COA samples, and source documentation for a gummy project.

Conclusion

Phosphatidylserine can be evaluated for gummy supplements, but a gummy project succeeds only when the buyer separates the powder question from the finished-product question. Confirm the destination-market category and dose-form position, choose source and grade against the target formula, review the powder specification with gummy-relevant parameters such as moisture and particle behavior, and run bench and stability trials that measure assay recovery, water activity, sensory, and uniformity. Keep US structure/function claims substantiated, notified, and disclaimed, and keep EU labels inside the authorized claim framework, where no PS health claims currently exist. With ingredient documents, a sample plan, and a contract manufacturer who controls the matrix, a PS gummy launch becomes a normal formulation project.

الأسئلة الشائعة

Can phosphatidylserine be used in gummies?

Yes, PS can be evaluated in gummy supplements, and commercial PS gummy products exist. Feasibility depends on the matrix: the brand must confirm assay recovery, water activity, stability, sensory fit, and dispersion in the actual gummy formula with samples and trials rather than relying on the powder COA alone.

What form of PS is used in gummies?

Most PS gummies use a powder-grade PS derived from soy or sunflower lecithin. The ingredient is dispersed into the gummy mass at a defined addition point; the exact grade and addition approach are confirmed with the contract manufacturer and the ingredient supplier.

Which PS source or grade is best for a gummy project?

There is no universal answer. Soy PS and sunflower PS differ mainly in allergen and label positioning; the grade (20%, 50%, or 70% PS) affects powder loading, flavor intensity, and cost per serving. The best choice is the one that meets target assay, sensory, and label needs in bench trials.

What specifications matter most for PS in a gummy matrix?

Assay, moisture, particle behavior, and source documentation matter most at the powder level; water activity, assay recovery, stability, and sensory matter at the finished-gummy level. Confirm the COA rows you need and request data when a row is not shown, such as particle size or method statements.

Can a PS gummy label make cognitive claims in the US or EU?

In the US, a structure/function claim is possible only with substantiation, an FDA notification within 30 days of first marketing, and the required disclaimer; disease claims are not allowed. In the EU, health claims require authorization under Regulation (EC) 1924/2006, and EFSA found the PS health claims it assessed were not substantiated, so cognitive or memory claims are not currently available.

What documents should a buyer request before ordering PS for a gummy launch?

Request the current specification, batch COA, TDS/SDS, source-specific statements, and any certificates in scope for the quoted grade, plus samples for bench trials. For the finished product, plan the release testing, water-activity and stability protocol, and label file with the contract manufacturer and regulatory adviser.

المصادر

• FDA: FDA 101 - Dietary Supplements
• FDA: Structure/Function Claims
• eCFR: 21 CFR 101.93 - Certain Types of Statements for Dietary Supplements
• eCFR: 21 CFR 111.70 - Specifications for dietary supplements
• FDA: Water Activity (aw) in Foods
• EUR-Lex: Directive 2002/46/EC on food supplements
• EUR-Lex: Regulation (EU) No 1169/2011 on the provision of food information to consumers
• EUR-Lex: Regulation (EC) No 1924/2006 on nutrition and health claims made on foods
• EFSA Journal: Scientific Opinion on health claims related to phosphatidyl serine (2010;8(10):1749)
• IFF Health: Sharp-PS technical handout - suitable formats including gummies

الخطوات التالية الموصى بها

• قم بمراجعة Phosphatidylserine صفحة المنتج.
• قارن Soy PS و Sunflower PS.
• يفحص إثبات التصنيع و الجودة والبحث والتطوير.